-
HC Wainwright Takes Bullish Stance On Two Cancer-Focused Pharma Companies
Thursday, March 8, 2018 - 4:23pmAnalysts at H.C. Wainwright initiated coverage Thursday on two pharmaceutical companies developing cancer-related vaccines and treatments. Interpace: Efficient Diagnosis, Expanding Reimbursement Coverage Analyst Raghuram Selvaraju initiated coverage on Interpace Diagnostics Group, Inc. (NASDAQ:...
Read More >>